drugset / Trial / NCT00525044
Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this trial is to investigate the efficacy and tolerance of Ambroxol lozenges 20 mg in the treatment of sore throat in patients with acute viral pharyngitis.
Timeline
- Start
- 2007-08-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ambroxol | Small molecule | 20 mg | — |